AKTS · Aktis Oncology, Inc. · Documents
$15.73
-1.03 (-6.15%)
At close · Oct 23
Return incl. dividend (before tax)
Market Cap
$874.89M
Shares
55.62M
Volume · Oct 23
241.76K
Avg daily vol (3M)
364.06K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| Investor Event Transcript | — | 2026-09-16 | 2026-09-30 | |
| 10-Q | — | 2026-08-13 | 2026-06-30 | |
| 8-K | — | 2026-08-13 | — | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-06-03 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-27 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-27 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-13 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-13 | 2026-06-30 | |
| 8-K | — | 2026-05-11 | — | |
| 10-Q | — | 2026-05-11 | 2026-03-31 | |
| Investor Event Transcript | — | 2026-05-05 | 2026-06-30 | |
| Investor Event Transcript | — | 2026-05-05 | 2026-06-30 | |
| 8-K | — | 2026-04-16 | 2026-04-15 | |
| 8-K | — | 2026-03-30 | — | |
| 10-K | — | 2026-03-30 | 2025-12-31 | |
| 8-K | — | 2026-01-12 | — | |
| S-1/A | — | 2026-01-07 | — | |
| S-1/A | — | 2026-01-05 | — | |
| S-1 | — | 2025-12-19 | — |
Showing 1–20 of 20 filings
Key facts
CIK
2035832
CUSIP
01021M104
13F (30d)
10 filings
10 filers
Visit website
Investor relations